BH,
I hope I'm wrong, I agree that trials should go much faster than they do, but given where things stand today, I don't know if the company will even be able to initiate one or more new trials with DCVax-Direct this year. In the first place, they'll want the FlaskWorks unit qualified to make it, then there will be no doubt that its qualified, but that could take time.
The question is, how will the trial be run. Will it have a control, or will all patients receive the vaccine. Will results be open, or will they only be available after XX patients have been dosed and in the trial for some minimal amount of time. Clinicians in the trial may very well see benefits far sooner, but how long will it be before any results are revealed.
I wish things were different, but I honestly can't say that I expect data to be revealed in much less time unless the trial is structured to permit it, which is doubtful.
Gary
News 
Market Data 
Discover 
